+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 90 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 67 Pages
  • Global
From
Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2024 - Product Thumbnail Image

Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • June 2022
  • 320 Pages
  • Global
From
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 871 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024

  • Clinical Trials
  • April 2024
  • 481 Pages
  • Global
From
Biotechnology Market Report by Product Type, Technology, Application, and Region 2024-2032 - Product Thumbnail Image

Biotechnology Market Report by Product Type, Technology, Application, and Region 2024-2032

  • Report
  • July 2024
  • 136 Pages
  • Global
From
Endometrial Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Endometrial Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chronic Lower Back Pain (CLBP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Lower Back Pain (CLBP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 293 Pages
  • Global
From
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 121 Pages
  • Middle East
From
Biotechnology Services Global Market Report 2024 - Product Thumbnail Image

Biotechnology Services Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

  • Report
  • July 2023
  • 78 Pages
  • Global
From
Smart Life Sciences Manufacturing Global Market Report 2024 - Product Thumbnail Image

Smart Life Sciences Manufacturing Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Loading Indicator